AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

FluINsure vaccine results presented at ICAAC.(Interscience Conference on Antimicrobial Agents and Chemotherapy)

Vaccine Weekly

| November 13, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 NOV 13 - (NewsRx.com & NewsRx.net) -- ID Biomedical announced that Dr. Scott Halperin of the Clinical Trials Research Center at IWK Health Center and Dalhousie University in Halifax, Nova Scotia, presented phase I clinical trial results for the FluINsure flu vaccine at the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Diego, California.

The FluINsure flu vaccine is the company's intranasally administered, nonliving vaccine for the prevention of influenza.

The clinical trial demonstrated that FluINsure, which is a trivalent product, was strongly immunogenic. Statistically-significant increases in both serum hemagglutination inhibiting (HAI) antibody and in virus-specific secretory immunoglobulin A (IgA) antibodies in the nose were shown for all three types of influenza viruses (A/H1N1, A/H3N2, and B) represented in the vaccine. Serum HAI antibody is an accepted correlate of immunity to influenza, and nasal secretory IgA antibody responses have received attention as an additional marker of disease resistance induced by live, attenuated nasal influenza vaccines.

In addition, FluINsure was well-tolerated by healthy adults in this randomized, double-blinded, and placebo-controlled trial. Only mild and short-lived runny nose was associated with the active vaccine when compared with placebo.

"Based on the results of this trial, the FluINsure flu vaccine appears to be quite competitive, in terms of both safety and immunogenicity, with other nasal flu vaccines," said Halperin.

"These are very encouraging results," said Dr. Louis Fries, ID Biomedical. "Across all subjects who got active vaccine, the average increase in serum HAI antibody levels to all three viruses was 3.2-fold. However, if you ...

Related articles from newspapers, magazines, journals, and more
Flu Vaccine Distributors Launch New Initiative.
Press release article from: PR Newswire October 4, 2006 700+ words
37% Increase in Flu Vaccine Supply Allows Record Number of Vaccinations...HIDA) today announced the formation of the Flu Vaccine Business Practices Initiative -- a group of flu vaccine distributors. Distributors joining the Initiative...
Demand for flu vaccine higher than usual
Newspaper article from: Roanoke Times & World News Duncan Adams October 14, 2009 700+ words
A regional shortage of seasonal flu vaccine mirrors a national shortage and ties...in the weeks ahead as more seasonal flu vaccine ships. Both Carilion Clinic in Roanoke...reported shortages Tuesday of the seasonal flu vaccine and are focusing first on vaccinating...
Learn about the Research Report Chinese Bird Flu Vaccine Industry, 2009.
Press release article from: Business Wire April 30, 2009 700+ words
...catalogue. Research Report Chinese Bird Flu Vaccine Industry, 2009 http://www.reportlinker...Research-Report-Chinese-Bird-Flu-Vaccine-Industry-2009.html Zoonosis refers...influenza A virus. Injecting the bird flu vaccine into animals' bodies may effectively...
Dynavax Presents Data From Novel Universal Flu Vaccine Candidate.
Press release article from: Business Wire April 30, 2009 700+ words
...preclinical data from its novel Universal Flu vaccine at two medical conferences this week...conserved antigens, Dynavax's Universal Flu vaccine is designed to offer protection against...Phase 1 clinical trial for its Universal Flu vaccine in the first half of 2010. "As we...
Dynavax's Flu Vaccine Shows Immunity to Divergent and Potentially Pandemic Flu...
Press release article from: PR Newswire August 21, 2006 700+ words
...preclinical data showing that its influenza (flu) vaccine confers immunity to widely divergent viral strains and has potential as a universal flu vaccine. Dynavax's flu vaccine is based on the company's proprietary TLR...
Dynavax's Universal Flu Vaccine Improves Response of Standard Flu Vaccines.
Press release article from: PR Newswire October 19, 2006 700+ words
...preclinical data that show its influenza (flu) vaccine can improve the immunogenicity of standard...that co-administration of Dynavax's flu vaccine with standard vaccine enhances the immune...of Health. Implications for Future Flu Vaccine Development "Our findings in flu give...
Flu vaccine shortage attracts profiteers.
Newspaper article from: Knight Ridder/Tribune Business News October 18, 2004 700+ words
...be coping with the worst shortage of flu vaccine in the nation's history, reports...state of Florida half a million doses of flu vaccine not approved for sale in this country...charging excessively high prices for flu vaccine. Flu shots normally cost about $20...
Supplier to add 2.6 million flu vaccine doses, U.S. says.
Newspaper article from: Dallas Morning News October 19, 2004 700+ words
...fears about the national shortage of flu vaccine Tuesday by announcing that the lone...If they can't even deal with the flu vaccine, how are they going to deal with bioterror...immunization program, saying, "The flu vaccine marketplace has been withering for years...
For more facts and information, see all results

Source: HighBeam Research, FluINsure vaccine results presented at ICAAC.(Interscience Conference...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA